Inventor · disambiguated record
Michael O'Callaghan
Also filed as: O'CALLAGHAN MICHAEL · O'CALLAGHAN MICHAEL W
2 granted patents·6 pending applications·14 citations·filing 2011–2022
59Inventor score
Top patents by PatentIndex Score
8 records- 0192US10308917B2Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereofGENZYME CORP·Filed 2016·Granted Jun 4, 2019·7 cites·13 claims
- 0287US9441029B2VEGF antagonist compositions and uses thereofSTEFANO JAMES·Filed 2011·Granted Sep 13, 2016·7 cites·32 claims
- 0348US2024374843A1Cannula assemblyASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 0444US2023038520A1Therapeutic adeno-associated virus comprising liver-specific promoters for treating pompe disease and lysosomal disordersASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 0543US2015152170A1Methods for increasing muscle contractilityVALERION THERAPEUTICS LLC·Filed 2013·Application pending·0 cites
- 0640US2022152221A1A method of treating cystic fibrosisASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 0737US2022133906A1Vectors comprising a nucleic acid encoding lysosomal enzymes fused to a lysosomal teargeting sequenceASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 0837US2022054656A1Therapeutic adeno-associated virus for treating pompe diseaseASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael O'Callaghan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →